GO:0042988 X11-like protein binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042988 (X11-like protein binding) is a molecular function defined as binding to X11-like protein, a neuron-specific adaptor protein.
• X11-like protein (also known as X11L, Mint2, or APBA2) interacts with the Alzheimer's amyloid precursor protein (APP) and regulates its trafficking and processing [2, 4].
• X11-like binding proteins modulate the production of amyloid-beta (Abeta), particularly Abeta42, through PDZ domain-dependent mechanisms.
• X11 and X11-like proteins regulate the levels of extrasynaptic glutamate receptors, impacting neuronal function.
• X11-like/Mint2 facilitates stress-induced phosphorylation of APP family members, linking cellular stress to Alzheimer's disease pathology.
• Dysregulation of X11-like protein binding is implicated in Alzheimer's disease, with X11-like colocalizing with neuritic plaques in patient brains.
Description
The Gene Ontology (GO) term GO:0042988, X11-like protein binding, describes a molecular function where a protein selectively binds to X11-like protein (X11L), a neuron-specific adaptor protein. This interaction is critical for neuronal development and function, as X11L and its family members (X11, X11L/Mint2) regulate the trafficking and processing of the amyloid precursor protein (APP), a key player in Alzheimer's disease [2, 4]. Understanding this binding event provides insights into the molecular mechanisms underlying neurodegenerative disorders and synaptic regulation [1, 3]. Researchers study X11-like protein binding to elucidate how adaptor proteins coordinate intracellular signaling and protein transport in neurons [5, 8]. The term is particularly relevant for investigations into APP metabolism, Abeta production, and the pathogenesis of Alzheimer's disease [6, 7].
X11-like protein binding At A Glance
| GO ID | GO:0042988 |
|---|---|
| GO term | X11-like protein binding |
| Ontology | molecular_function |
| Synonym | X11L binding |
| Major function | Binding to X11-like protein, a neuron-specific adaptor protein, to regulate protein trafficking and processing |
| Related genes | APBA2 (X11L/Mint2), APP, APBA1 (X11/Mint1), APBB1 (Fe65) |
| Associated diseases | Alzheimer's disease, neurodegenerative disorders |
| Research methods | Co-immunoprecipitation, GST pull-down, FRET, CRISPR knockout |
What Is GO:0042988?
X11-like protein binding (GO:0042988) is a molecular function defined as the selective interaction of a protein with X11-like protein, a neuron-specific adaptor protein. This binding typically involves specific domains, such as the PDZ domain of X11L, and is essential for mediating protein-protein interactions that regulate neuronal signaling and APP processing [1, 6].
Why Is X11-like protein binding Important in Cell Biology?
X11-like protein binding is crucial for neuronal function because it modulates the metabolism of APP, the precursor of amyloid-beta peptides that aggregate in Alzheimer's disease [2, 4]. Disruption of this binding can lead to altered APP processing and increased Abeta42 production, a hallmark of Alzheimer's pathology. Moreover, X11-like proteins regulate extrasynaptic glutamate receptors, influencing synaptic transmission and excitotoxicity. Thus, understanding this molecular function is essential for developing therapeutic strategies targeting neurodegenerative diseases [3, 8].
• Regulates APP trafficking and processing, affecting Abeta production [2, 5].
• Modulates extrasynaptic glutamate receptor levels, impacting neuronal excitability.
• Involved in stress-induced phosphorylation of APP family members.
• Colocalizes with amyloid plaques in Alzheimer's disease brains.
• PDZ domain-dependent suppression of NF-kappaB/p65-induced Abeta42 production.
• Genetic mapping links APBA2 (X11L) to Alzheimer's disease susceptibility.
• Potential target for therapeutic intervention in Alzheimer's disease.
• Key to understanding neuron-specific adaptor protein networks.
Molecular Mechanism of X11-like protein binding
Domain-Specific Interaction
In simple terms: X11-like protein uses specific domains to grab onto other proteins.
X11-like protein (X11L/Mint2) contains a PDZ domain that mediates binding to target proteins, such as APP. This PDZ domain-dependent interaction is crucial for suppressing NF-kappaB/p65-induced Abeta42 production. Additionally, the phosphotyrosine-binding (PTB) domain of X11L interacts with the YENPTY motif of APP, facilitating intracellular trafficking.
Regulation of APP Trafficking
In simple terms: Binding to X11-like protein controls where APP goes inside the cell.
X11-like protein binding regulates the intracellular trafficking of APP, directing it away from amyloidogenic processing pathways. This interaction influences the localization of APP to specific cellular compartments, thereby affecting Abeta production.
Modulation of Abeta Production
In simple terms: X11-like binding can decrease the production of toxic amyloid-beta peptides.
Through PDZ domain-dependent mechanisms, X11-like protein suppresses the production of Abeta42, a highly amyloidogenic peptide. XB51 isoforms further mediate Abeta production in both X11L-dependent and -independent manners.
Stress-Induced Phosphorylation
In simple terms: Cellular stress triggers X11-like protein to help phosphorylate APP.
X11-like/Mint2 facilitates stress-induced phosphorylation of APP family members, linking stress signaling to APP metabolism. This phosphorylation may alter APP processing and contribute to Alzheimer's disease pathogenesis.
Regulation of Glutamate Receptors
In simple terms: X11-like proteins control the number of glutamate receptors outside synapses.
X11 and X11-like proteins regulate the levels of extrasynaptic glutamate receptors, impacting neuronal excitability and synaptic transmission. This regulation is critical for preventing excitotoxicity and maintaining neuronal health.
Key Genes Involved in GO:0042988 X11-like protein binding
The following genes and proteins are key players in X11-like protein binding and its associated cellular functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| APBA2 (X11L/Mint2) | Neuron-specific adaptor protein; binds APP and regulates trafficking | Central to GO:0042988; linked to Alzheimer's disease [2, 4] |
| APP | Amyloid precursor protein; substrate for X11L binding | Alzheimer's disease pathogenesis [2, 5] |
| APBA1 (X11/Mint1) | Neuronal adaptor protein; interacts with APP | Modulates APP processing [1, 8] |
| APBB1 (Fe65) | Adaptor protein; binds APP | Competes with X11L for APP binding |
| APBB2 (Fe65-like) | Adaptor protein; interacts with APP | Genetic mapping in Alzheimer's disease |
| XB51 | Isoforms mediating Abeta production | X11L-dependent and -independent Abeta regulation |
| NF-kappaB/p65 | Transcription factor; induces Abeta42 production | Suppressed by X11L PDZ domain |
| GRIN1 | Glutamate receptor subunit | Regulated by X11/X11L at extrasynaptic sites |
| GRIN2A | Glutamate receptor subunit | Regulated by X11/X11L |
| GRIN2B | Glutamate receptor subunit | Regulated by X11/X11L |
| PSEN1 | Presenilin 1; gamma-secretase component | APP processing |
| PSEN2 | Presenilin 2; gamma-secretase component | APP processing |
| BACE1 | Beta-secretase; cleaves APP | APP processing |
| MAPT | Microtubule-associated protein tau | Neurodegeneration |
| APOE | Apolipoprotein E; lipid transport | Alzheimer's risk factor |
| CLU | Clusterin; chaperone | Alzheimer's risk factor |
| PICALM | Phosphatidylinositol binding clathrin assembly protein | APP trafficking |
| SORL1 | Sortilin-related receptor; APP trafficking | Alzheimer's risk factor |
How Is X11-like protein binding Regulated?
X11-like protein binding is regulated at multiple levels. The interaction with APP is modulated by phosphorylation of APP's YENPTY motif, which can affect binding affinity. Stress-induced phosphorylation of APP family members by X11-like/Mint2 further regulates this interaction. Additionally, the expression levels of X11-like protein itself are controlled by neuronal activity and developmental cues. The PDZ domain-mediated suppression of NF-kappaB/p65-induced Abeta42 production highlights a regulatory feedback loop.
X11-like protein binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APBA2 (X11L) | Alzheimer's disease; Abeta production | Knockout mice, overexpression cell lines [2, 6] |
| APP | Alzheimer's disease; amyloid plaques | Knock-in mice with APP mutations |
| GRIN1/GRIN2A/GRIN2B | Excitotoxicity; synaptic dysfunction | Conditional knockout mice |
| PSEN1 | Early-onset Alzheimer's disease | Point mutation knock-in |
| APBB1 (Fe65) | Alzheimer's disease; APP processing | Knockout mice |
Alzheimer's Disease
X11-like protein binding is directly implicated in Alzheimer's disease through its role in APP processing and Abeta production. X11-like colocalizes with neuritic plaques in Alzheimer's disease brains, and its binding to APP suppresses amyloidogenic processing [4, 6]. Disruption of this interaction may lead to increased Abeta42 production, a key event in Alzheimer's pathogenesis.
Neurodegeneration and Synaptic Dysfunction
X11 and X11-like proteins regulate extrasynaptic glutamate receptors, and their dysfunction can lead to excitotoxicity and synaptic impairment, contributing to neurodegeneration. Stress-induced phosphorylation of APP by X11-like/Mint2 further links cellular stress to neurodegenerative pathways.
Genetic Susceptibility
Genetic mapping of APBA2 (X11L) and related genes has identified variants that may influence Alzheimer's disease susceptibility. These findings underscore the importance of X11-like protein binding in disease genetics.
From X11-like protein binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does X11L binding to APP affect Abeta42 levels? | APBA2 knockout cell line (e.g., HEK293) |
| How does X11L phosphorylation regulate APP processing? | Point mutation knock-in of APP YENPTY motif |
| What is the role of X11L PDZ domain in NF-kappaB suppression? | PDZ domain deletion mutant |
| Does X11L regulate extrasynaptic glutamate receptors in vivo? | Conditional APBA2 knockout mice |
| Can overexpression of X11L rescue Alzheimer's phenotypes? | Transgenic APP mice with X11L overexpression |
| How do X11L isoforms affect Abeta production? | XB51 isoform-specific knockout |
How to Study the X11-like protein binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-IP | Protein-protein interactions | Detect X11L-APP binding in cell lysates |
| GST pull-down | Direct binding and domain mapping | Identify PDZ domain interactions |
| FRET | Real-time binding dynamics | Visualize X11L-APP interaction in live neurons |
| CRISPR knockout | Loss-of-function effects | Study APBA2 knockout on Abeta levels |
| Western blot | Protein expression and phosphorylation | Assess APP phosphorylation by X11L |
| ELISA | Abeta42 quantification | Measure Abeta42 in conditioned media |
| Immunohistochemistry | Tissue localization | Detect X11L in Alzheimer's brain plaques |
| RNA-seq | Transcriptional changes | Analyze gene expression upon X11L manipulation |
Co-Immunoprecipitation (Co-IP)
Co-IP is used to detect physical interactions between X11-like protein and its binding partners, such as APP. This method can confirm binding in endogenous settings and identify novel interactors [2, 4].
GST Pull-Down Assays
GST pull-down assays with recombinant X11L domains (e.g., PDZ, PTB) can map specific binding regions and quantify interaction affinities.
Fluorescence Resonance Energy Transfer (FRET)
FRET can visualize X11-like protein binding in live cells, providing spatial and temporal dynamics of interactions.
CRISPR/Cas9 Genome Editing
CRISPR knockout of APBA2 or point mutations in APP can elucidate the functional consequences of X11-like protein binding on Abeta production and neuronal physiology [1, 6].
How CRISPR Can Be Used to Study GO:0042988 X11-like protein binding
Knockout
CRISPR knockout of APBA2 (X11L) in neuronal cell lines or mice can reveal its role in APP processing and Abeta production. For example, APBA2 knockout increases Abeta42 levels, confirming its suppressive function.
Point Mutation
Introducing point mutations in the APP YENPTY motif or X11L PDZ domain can disrupt binding and elucidate specific interaction requirements. Such models help dissect the molecular determinants of X11-like protein binding.
Knock-in
Knock-in of disease-associated mutations (e.g., APP Swedish mutation) in combination with X11L tagging allows tracking of binding dynamics in vivo.
Overexpression
Overexpression of X11L or its domains can rescue phenotypes in Alzheimer's models, providing evidence for therapeutic potential.
How EDITGENE Supports X11-like protein binding Research
Researchers studying X11-like protein binding-related genes often need to determine whether a candidate gene is causally involved in neuronal function or disease. EDITGENE provides comprehensive CRISPR services to create precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for X11-like protein binding research.
Frequently Asked Questions About X11-like protein binding
What is X11-like protein binding?
X11-like protein binding (GO:0042988) is a molecular function where a protein binds to X11-like protein, a neuron-specific adaptor protein involved in APP trafficking and Abeta production [1, 2].
What genes are involved in X11-like protein binding?
Key genes include APBA2 (encoding X11L/Mint2), APP, APBA1 (X11), and APBB1 (Fe65) [2, 4, 7].
How does X11-like protein binding affect Alzheimer's disease?
X11-like protein binding regulates APP processing and suppresses Abeta42 production; disruption may increase amyloidogenic processing, contributing to Alzheimer's disease [4, 6].
What is the role of X11L PDZ domain?
The PDZ domain of X11L mediates binding to target proteins and is required for suppressing NF-kappaB/p65-induced Abeta42 production.
Which diseases are associated with X11-like protein binding?
Alzheimer's disease and other neurodegenerative disorders are linked to X11-like protein binding dysfunction [3, 4].
How can I study X11-like protein binding in the lab?
Common methods include co-immunoprecipitation, GST pull-down, FRET, and CRISPR knockout models [2, 6].
What are the synonyms for X11-like protein binding?
The synonym is X11L binding.
What is the GO ID for X11-like protein binding?
The GO ID is GO:0042988.
Does X11-like protein binding regulate glutamate receptors?
Yes, X11 and X11-like proteins regulate the levels of extrasynaptic glutamate receptors.
Can CRISPR be used to study X11-like protein binding?
Yes, CRISPR knockout of APBA2 or point mutations in APP can elucidate the functional consequences of X11-like protein binding [1, 6].
Conclusion
X11-like protein binding (GO:0042988) is a critical molecular function in neuronal cells, regulating APP trafficking, Abeta production, and glutamate receptor levels. Its dysregulation is implicated in Alzheimer's disease and neurodegeneration. Understanding this interaction offers potential therapeutic targets and requires advanced research tools such as CRISPR models and bioinformatics analysis. EDITGENE provides comprehensive services to support such investigations.
References
- 1. Motodate R et al.. 2019. X11 and X11-like proteins regulate the level of extrasynaptic glutamate receptors.. J Neurochem 148(4):480-498 PMID: 30411795
- 2. Saito Y et al.. 2011. Intracellular trafficking of the amyloid β-protein precursor (APP) regulated by novel function of X11-like.. PLoS One 6(7):e22108 PMID: 21818298
- 3. Taru H et al.. 2004. Facilitation of stress-induced phosphorylation of beta-amyloid precursor protein family members by X11-like/Mint2 protein.. J Biol Chem 279(20):21628-36 PMID: 14970211
- 4. McLoughlin DM et al.. 1999. Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease.. Eur J Neurosci 11(6):1988-94 PMID: 10336668
- 5. Sumioka A et al.. 2003. XB51 isoforms mediate Alzheimer's beta-amyloid peptide production by X11L (X11-like protein)-dependent and -independent mechanisms.. Biochem J 374(Pt 1):261-8 PMID: 12780348
- 6. Tomita S et al.. 2000. PDZ domain-dependent suppression of NF-kappaB/p65-induced Abeta42 production by a neuron-specific X11-like protein.. J Biol Chem 275(17):13056-60 PMID: 10777610
- 7. Blanco G et al.. 1998. Mapping of the human and murine X11-like genes (APBA2 and apba2), the murine Fe65 gene (Apbb1), and the human Fe65-like gene (APBB2): genes encoding phosphotyrosine-binding domain proteins that interact with the Alzheimer's disease amyloid precursor protein.. Mamm Genome 9(6):473-5 PMID: 9585438
- 8. Taru H et al.. 2009. Regulation of the physiological function and metabolism of AbetaPP by AbetaPP binding proteins.. J Alzheimers Dis 18(2):253-65 PMID: 19584434
